Inhibition of advanced glycation end products: an implicit goal in clinical medicine for the treatment of diabetic nephropathy?. [No authors listed] T Miyata, Y Izuhara - Annals of the New York Academy of …, 2008 - Wiley Online Library GSID: Ya-PM2cEaFAJ
Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?. Cooper ME, Coughlan MT. MT Coughlan, ME Cooper… - Annals of the New York …, 2005 - Wiley Online Library GSID: y4lzwgg2VLUJ
Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes. [No authors listed] J Peyroux, M Sternberg - Pathologie Biologie, 2006 - Elsevier GSID: 6ub5KiOa5C4J
Protein and low molecular mass thiols as targets and inhibitors of glycation reactions. Davies MJ. J Zeng, MJ Davies - Chemical research in toxicology, 2006 - ACS Publications GSID: BZusDttXFkgJ
Therapeutic strategies in the treatment of diabetic nephropathy-a translational medicine approach. [No authors listed] IM Shah, SP Mackay, GA McKay - Current medicinal chemistry, 2009 - ingentaconnect.com GSID: AoJjn1Hh89UJ